IONS
Ionis Pharmaceuticals Inc
NASDAQ: IONS · HEALTHCARE · BIOTECHNOLOGY
$74.76
-0.09% today
Updated 2026-04-30
Market cap
$11.85B
P/E ratio
—
P/S ratio
12.56x
EPS (TTM)
$-2.38
Dividend yield
—
52W range
$30 – $87
Volume
2.2M
Ionis Pharmaceuticals Inc (IONS) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $166.37M | $255.91M | $258.86M | $574.15M | $657.18M | $550.48M | $484.89M | $545.69M | $847.16M | $955.81M | $956.11M | $912.47M | $1.32B | $2.67B | $3.23B | $2.39B | $2.61B | $2.53B | $2.99B | $3.00B |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets | $105.86M | $206.20M | $207.32M | $518.38M | $596.13M | $483.14M | $360.14M | $423.44M | $735.51M | $836.60M | $837.00M | $797.93M | $1.17B | $2.21B | $2.72B | $2.13B | $2.35B | $2.20B | $2.64B | $2.62B |
| Total liabilities | $163.71M | $158.00M | $248.62M | $469.90M | $355.12M | $305.94M | $313.46M | $362.92M | $468.77M | $698.03M | $755.32M | $812.90M | $903.30M | $1.48B | $1.55B | $1.55B | $1.84B | $1.96B | $2.60B | $2.42B |
| Current liabilities | $23.79M | $25.14M | $62.20M | $124.70M | $111.44M | $105.89M | $76.11M | $74.32M | $97.81M | $115.33M | $148.88M | $133.78M | $224.74M | $280.29M | $273.00M | $290.00M | $241.00M | $311.56M | $448.09M | $309.32M |
| Long-term debt | $139.91M | $132.82M | $162.86M | $172.44M | $136.58M | $143.04M | $215.45M | $221.94M | $228.16M | $454.90M | $397.57M | $500.63M | $592.88M | $628.06M | $769.96M | $515.70M | $1.22B | $1.18B | $1.23B | $1.25B |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | $-770.85M | $-816.75M | $-827.75M | $-839.71M | $-696.15M | $-756.69M | $-841.49M | $-906.97M | $-967.61M | $-1.01B | $-1.09B | $-1.18B | $-1.19B | $-967.29M | $-707.53M | $-1.25B | $-1.16B | $-1.43B | $-1.80B | $-2.25B |
| Accounts receivable | $3.92M | $2.40M | $6.18M | $4.12M | $10.90M | $1.24M | $6.92M | $522000.00 | $11.10M | $3.90M | $11.36M | $108.04M | $62.95M | $12.76M | $63.00M | $76.00M | $62.00M | $25.54M | $97.78M | $92.19M |
| Inventory | $951000.00 | $861000.00 | $2.82M | $2.72M | $2.77M | $2.48M | $4.14M | $6.12M | $8.03M | $6.29M | $6.90M | $7.49M | $9.98M | $8.58M | $18.18M | $21.96M | $24.81M | $22.03M | $7.44M | $12.51M |
| Goodwill | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |